Cargando…
Substandard drugs: a potential crisis for public health
Poor-quality medicines present a serious public health problem, particularly in emerging economies and developing countries, and may have a significant impact on the national clinical and economic burden. Attention has largely focused on the increasing availability of deliberately falsified drugs, b...
Autores principales: | Johnston, Atholl, Holt, David W |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Blackwell Science Inc
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4137817/ https://www.ncbi.nlm.nih.gov/pubmed/24286459 http://dx.doi.org/10.1111/bcp.12298 |
Ejemplares similares
-
Substandard anti-malarial drugs in Burkina Faso
por: Tipke, Maike, et al.
Publicado: (2008) -
Substandard Lives and Their Assessment in Life Assurance
Publicado: (1929) -
Effectiveness, safety and cost of drug substitution in hypertension
por: Johnston, Atholl, et al.
Publicado: (2010) -
Revisiting the blind spot of substandard and fake drugs as drivers of antimicrobial resistance in LMICs
por: Gulumbe, Bashar H., et al.
Publicado: (2023) -
Legal Uncertainty—The Gray Area around Substandard Medicines: Where Public Health Meets Law
por: Olliaro, Eugenia, et al.
Publicado: (2020)